Dr. Mustafa Diken received his Ph.D. in tumor immunology from Johannes Gutenberg University, Mainz and is currently serving as Vice President Vaccines & Immunology at BioNTech SE. His research focuses on the development of novel cancer and infectious disease vaccines based on antigen-encoding messenger RNA (mRNA). His research led to novel mRNA vaccines which are currently being tested in several clinical trials.